WednesdaySep 30, 2020 3:45 pm

Can Psilocybin Treat OCD?

A new study that was authored and published in the Journal of Psychedelic Studies by Eddie Jacobs, a neuroethicist, suggests that psilocybin exhibits great potential as a treatment for obsessive compulsive disorder (“OCD”). Jacobs, who is from the University of Oxford and King’s College London, admits that the inadequacy of studies that research the therapeutic potential of psilocybin in the treatment of OCD is surprising. Psilocybin is a psychedelic compound that is found in magic mushrooms. In the recent past, the FDA granted psilocybin breakthrough status designation for its use as an alternative therapy for major depressive disorder and treatment-resistant…

Continue Reading

WednesdaySep 30, 2020 2:30 pm

Pure Extract Poised to Benefit as Mainstream Society Embraces Functional Mushrooms

Following $1.25 million donation, UC Berkeley launching Center for the Science of Psychedelics Pure Extract Technologies Inc. expanding into functional and medicinal mushroom market Psychedelic compounds increasingly being studied to treat wide range of physical, mental conditions Pure Extracts plans to obtain a Natural Health Products Site License from Health Canada to buy, sell, functional mushroom products For hundreds of years, medicinal mushrooms have been revered among both ancient and modern cultures throughout the world for their nutritional and medicinal qualities. Pure Extract Technologies, a private plant-based Canadian extraction company headquartered in British Columbia, is leveraging the latest in science…

Continue Reading

TuesdaySep 29, 2020 2:45 pm

Why Psychedelics Should Be Normalized and Legalized

An updated meta-survey that was published in Our World in Data in April 2018 shares data from various mental wellness studies that indicates that people suffering from mental ailments and substance abuse range in the billions worldwide. Similarly, WHO published information that showed that between the years 1990 and 2013, the number of people suffering from anxiety and depression increased to 615 million from 416 million, which equates to an almost 50% increment. Nearly 10% of the global population is affected, with mental illnesses making up 30% of the world’s non-fatal disease burden. Earlier in 2018, mental health was declared…

Continue Reading

MondaySep 28, 2020 3:30 pm

Canada Sees Spike in Licensed Ayahuasca Churches

The Centre of Universal Illumination Luz Divina, located in Winnipeg, Manitoba recently became the 6th religious group to receive government exemption to legally import and use ayahuasca. The organization is part of a number of religious groups that have permission from the Canadian government to use ayahuasca. This comes at a time when researchers and advocates are calling for more research to be done on the potential benefits of the psychedelic substance as well as its decriminalization. Thus far, Health Canada has granted only 6 exemptions for churches in Toronto, Winnipeg and Montreal. The exemptions allow them to import and…

Continue Reading

FridaySep 25, 2020 2:30 pm

Ann Arbor City Council Votes to Decriminalize Psychedelics

Earlier on Monday, the Ann Arbor, Michigan City Council unanimously voted to decriminalize a wide range of psychedelic substances. Decriminalize Nature Ann Arbor, an organization that advocates for decriminalization of entheogenic plants such as ayahuasca and psilocybin, with different branches across the country, brought the proposal before the city council. Council members Jeff Hayner (D) and Anne Bannister (D) sponsored the measure, which is similar to previously approved measures in Santa Cruz and Oakland, California. In a recent press release, Hayner said that the decriminalization of naturally-occurring psychedelic medicines is necessary for progress and that we could no longer keep…

Continue Reading

FridaySep 25, 2020 9:00 am

Did You Celebrate 9/20? A Peek into the Psychedelic Mushrooms Holiday

Each year, millions of stoners around the world celebrate 4/20, which is the international marijuana holiday and also 4/19, also known as Bicycle Day; which is the anniversary of the day Albert Hoffman, a chemist, intentionally took LSD then rode his bike through Basel in Switzerland. Unlike 4/19 which was established in 1943 and 4/20 which was established in the 1970s, September 20 is fairly new in the holiday scene. In 2015, Nicholas Reville, who is a mushroom advocate from Providence in Rhode Island, christened September 20 an educational day of action. This is aimed at encouraging more discussions around…

Continue Reading

WednesdaySep 23, 2020 2:15 pm

Compass Pathways (NASDAQ: CMPS) Begins Trading on Nasdaq Global Select Market

Last Friday, psychedelic drug company Compass Pathways (NASDAQ: CMPS) began trading on the Nasdaq Global Select Market. Its shares surged 70.6% and closed at $29.00. This lifted the market cap to almost $1 billion. The launch comes after Compass Pathways reportedly upsized pricing for its IPO. The company is backed by Peter Thiel, PayPal cofounder and billionaire investor. Compass Pathways is a London-based company that is studying hallucinogenic mushrooms as a therapeutic. The company’s IPO was $17 per share, which was an increase from the initial $14-$16 expectation that had been announced earlier in the week. This put the valuation…

Continue Reading

WednesdaySep 23, 2020 1:51 pm

United Bid to Liberalize Use of Psilocybin Strengthens

Leading UK scientists, policy group call for rescheduling of psilocybin amid looming mental health crisis Sent to the Home Office with statements of support from leading scientists, paper urges for psilocybin use on a research-only model Cybin Corp. to capitalize on international expansion of psilocybin use as a company active in both research, nonclinical spaces The United Kingdom (“UK”) is joining other countries, including Canada, in a push to facilitate the wider use of psilocybin, a naturally occurring compound found in mushrooms. Focusing on psychedelic and nutraceutical products, Cybin Corp. is poised to leverage the growing global momentum the compound is…

Continue Reading

TuesdaySep 22, 2020 4:29 pm

Survey Shows Increased Dutch Interest in Psychedelics During Pandemic

In the Netherlands, the coronavirus pandemic and resulting lockdown significantly decreased drug use, particularly the use of ecstasy and cocaine. Its capital, Amsterdam, recorded the biggest decrease. The government-imposed restrictions that resulted in the closing of restaurants, cafes and clubs on March 15 led to home confinement for a majority of people. This presented a unique situation for researchers to measure drug use without the presence of an active night life or tourism in the society. The KWR Water Research Institute conducted an analysis of waste water in Amsterdam, Eindhoven and Utrecht between March 18 and 24 this year. The…

Continue Reading

MondaySep 21, 2020 3:15 pm

Psychedelic Treatments: Bringing Out the Truth

In a discussion with Charles Raison, Psych Congress co-chair and professor at the University of Wisconsin-Madison, Penn., psychedelics, when used as treatments were more than just finding another way to reduce a disease’s symptoms. Andrew D. Penn is also a Psych Congress member and an associate clinical professor at the University of California. He explains that psychedelics would redefine psychiatry as the substances focused on healing. The field of psychiatry has tried to find a means to cure people, without success. Instead, the field has succeeded in reducing or rather, managing symptoms, which is not necessarily a bad thing. It…

Continue Reading

PsychedelicNewsWire Currently Accepts

Bitcoin

Bitcoin

Bitcoin Cash

Bitcoin Cash

Ethereum

Ethereum

Litecoin

Litecoin

USD Coin

USD Coin

Contact us: 415.949.5050